| Literature DB >> 20831296 |
Abstract
Economists engaged in comparative effectiveness research (CER) commonly adopt particular value judgements that underpin many of their methods. Two of these are the idea of a 'societal perspective' and that the foundation of values in measures of health outcome is individual preferences. This article takes issue with both value judgements and argues instead that the values to be adopted are not ones to be determined a priori or independently of the context of the analysis. Indeed, the first task of analysts is to discover these values by early and ongoing consultation with the commissioners of the CER. The same arguments apply to the practice of cost-effectiveness analysis.Mesh:
Year: 2010 PMID: 20831296 DOI: 10.2165/11535270-000000000-00000
Source DB: PubMed Journal: Pharmacoeconomics ISSN: 1170-7690 Impact factor: 4.981